Mettler-Toledo International, Inc. (NYSE:MTD) Given Consensus Recommendation of “Hold” by Brokerages

Mettler-Toledo International, Inc. (NYSE:MTD) has earned an average recommendation of “Hold” from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $1,408.5455.

A number of brokerages recently issued reports on MTD. JPMorgan Chase & Co. decreased their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Barclays decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Wolfe Research began coverage on shares of Mettler-Toledo International in a report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Robert W. Baird decreased their price target on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Finally, Wall Street Zen lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th.

Hedge Funds Weigh In On Mettler-Toledo International

Several hedge funds and other institutional investors have recently made changes to their positions in MTD. Geneos Wealth Management Inc. lifted its holdings in shares of Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 30 shares in the last quarter. Baird Financial Group Inc. lifted its holdings in shares of Mettler-Toledo International by 3.1% during the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after acquiring an additional 40 shares in the last quarter. Jump Financial LLC lifted its holdings in shares of Mettler-Toledo International by 44.6% during the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after acquiring an additional 125 shares in the last quarter. Cerity Partners LLC lifted its holdings in shares of Mettler-Toledo International by 10.8% during the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after acquiring an additional 392 shares in the last quarter. Finally, AXA S.A. lifted its holdings in shares of Mettler-Toledo International by 2.9% during the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock valued at $5,433,000 after acquiring an additional 131 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,263.76 on Wednesday. Mettler-Toledo International has a 1 year low of $1,023.05 and a 1 year high of $1,525.17. The firm’s 50 day moving average price is $1,178.25 and its 200 day moving average price is $1,293.13. The firm has a market cap of $25.54 billion, a P/E ratio of 29.64, a price-to-earnings-growth ratio of 2.64 and a beta of 1.27.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. During the same quarter last year, the business earned $8.19 earnings per share. Mettler-Toledo International’s revenue was up 7.2% compared to the same quarter last year. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities analysts predict that Mettler-Toledo International will post 46.6 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.